Halaman 4 - Kanker payudara Dokter Terbaik - TOP-171 dokter

Prof. Dr. Cemil Bilir adalah seorang dokter onkologi medis yang sangat berkualifikasi dengan keanggotaan bergengsi di ASCO dan ESMO.

• Pengalaman lebih dari 15 tahun di bidang onkologi medis
• Menempuh pendidikan di Universitas Bulent Ecevit dan Universitas Recep Tayyip Erdogan
• Pengalaman riset di Northeastern University di AS
• Profesor di Fakultas Kedokteran Universitas Sakarya
• Spesialisasi dalam pengobatan dan penelitian kanker payudara

Prof. Gul Alco berspesialisasi dalam pengobatan kanker payudara menggunakan teknik onkologi radiasi tingkat lanjut di Rumah Sakit Distrik Medipol Acibadem.

• Berpengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Profesor di Departemen Onkologi Radiasi Universitas Medipol Istanbul
• Menempuh pendidikan di Universitas Istanbul dan Universitas Kadir Has
• Mantan Lektor Kepala di Universitas Demiroglu Bilim

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Lebih dari dua dekade keahlian bedah, termasuk pelatihan lanjutan dalam bedah kanker onkologi di Fakultas Kedokteran Cerrahpaşa.

• Spesialisasi dalam bedah laparoskopi dan anti-refluks sejak 2002
• Pelatihan terbaru dalam bedah laparoskopi tingkat lanjut dan bariatrik
• Praktik di Rumah Sakit Büyük Anadolu

Prof. Madya Nail Paksoy membawa keahlian mendalam dalam pengobatan kanker payudara, dengan Sertifikasi Dewan ESMO dan keterlibatan dalam uji klinis internasional.

• Spesialisasi dalam pengobatan kanker payudara HER2-positif
• Berpartisipasi aktif dalam uji coba onkologi utama termasuk Astefania (ROCHE)
• Penelitian yang diterbitkan mengenai hasil kanker payudara metastatik

Dr. Salman berspesialisasi dalam pengobatan kanker payudara di Rumah Sakit Internasional Medicalpoint, menawarkan perawatan pribadi dengan profil genomik tingkat lanjut.

• Pengalaman lebih dari 15 tahun di bidang onkologi medis
• Ahli dalam terapi target dan imunoterapi untuk kanker payudara
• Anggota European Society of Medical Oncology dan American Society of Clinical Oncology
• Pengunjung akademik di Moffitt Cancer Center di Tampa, Florida

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Spesialis dalam viroterapi selama 30+ tahun – Dr. Jaunalksne menghadirkan pendekatan imunologis mutakhir pada pengobatan kanker payudara.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Pengalaman 30+ tahun dalam penelitian dan praktik imunologi

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Prof. Dr. Seyda Gunduz mengkhususkan diri dalam bidang onkologi di Rumah Sakit Liv Universitas Istinye Bahcesehir, yang berfokus pada kasus kanker payudara.

• Mengevaluasi dan mengobati kasus massa payudara dengan penuh keahlian
• Berpengalaman luas dalam onkologi dengan gelar medis
• Bekerja di rumah sakit universitas ternama

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Ozden memiliki spesialisasi dalam onkologi medis dengan fokus pada kanker payudara, membawa pengalaman berdedikasi selama bertahun-tahun di VM Medical Park Pendik Hospital.

• Menyelesaikan pendidikan di Fakultas Kedokteran Cerrahpaşa Universitas Istanbul
• Menyelesaikan subspesialisasi Onkologi Medis di Universitas Kocaeli
• Memiliki pengalaman lebih dari satu dekade dalam kedokteran penyakit dalam dan onkologi

Dr. Alemdar berspesialisasi dalam perawatan kanker payudara dengan pelatihan ekstensif dalam onkologi medis di Universitas Akdeniz.

• Ahli onkologi medis bersertifikat dengan pengalaman lebih dari 17 tahun
• Bekerja di Medical Park Antalya Hospital Complex – pusat onkologi terkemuka
• Praktik terfokus pada diagnosis dan perawatan kanker payudara

Spesialis dalam bedah onkoplastik payudara – Dr. Zengel melakukan mastektomi dengan pengawetan kulit dan payudara serta rekonstruksi simultan.

• Lebih dari 25 tahun pengalaman dalam bedah payudara
• Ahli dalam teknik ROLL dan SNOLL untuk lokalisasi tumor yang tepat
• Associate Professor Bedah Umum
• Anggota Asosiasi Penyakit Payudara Izmir

Dr. Gutman didiagnosis berspesialisasi dalam bedah kanker payudara di Pusat Medis Assuta.

• Onkosurgeri dengan keahlian dalam prosedur kanker payudara
• Bekerja di salah satu pusat medis terkemuka di Israel
• Berfokus untuk menyediakan rencana perawatan yang dipersonalisasi

Ahli onkologi dan radiologi yang berspesialisasi dalam kanker payudara di Assuta Medical Center.

• Keahlian ganda dalam onkologi dan radiologi
• Fokus pada perawatan kanker payudara yang komprehensif
• Praktik di pusat medis terkemuka di Israel

Kepala Departemen Bedah Payudara di Assuta Medical Center – Moshe Papa memimpin tim khusus yang berfokus pada perawatan kanker payudara.

• Ahli mammologi dengan pengalaman luas dalam kesehatan payudara
• Mengawasi departemen bedah payudara yang berdedikasi
• Bekerja di salah satu pusat medis terkemuka di Israel

Dr. Kinas berspesialisasi dalam bedah payudara dan prosedur onkologi, menawarkan perawatan ahli di Rumah Sakit Büyük Anadolu.

• Berpengalaman dalam berbagai bedah kanker termasuk payudara, pankreas, dan kolon
• Ahli dalam bedah metabolik bariatrik dan diabetes
• Fokus pada rencana perawatan kanker yang komprehensif

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.